Viewing Study NCT05925127


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-03-04 @ 10:24 PM
Study NCT ID: NCT05925127
Status: COMPLETED
Last Update Posted: 2024-12-13
First Post: 2023-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines
Sponsor: Novavax
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module